<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03588338</url>
  </required_header>
  <id_info>
    <org_study_id>2017/1081</org_study_id>
    <nct_id>NCT03588338</nct_id>
  </id_info>
  <brief_title>Paracetamol on Postoperative Nausea and Vomiting</brief_title>
  <official_title>The Effect of Paracetamol on Postoperative Nausea and Vomiting Following Maxillofacial Surgery: a Prospective, Randomised, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aydin Adnan Menderes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aydin Adnan Menderes University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The drugs with both high potency and low side effects are preferred in the prevention of&#xD;
      postoperative nausea and vomiting (PONV) which is a common problem. This prospective&#xD;
      randomized study aimed to compare the efficacy of paracetamol on PONV in adults undergoing&#xD;
      maxillofacial surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred-twenty patients are randomly divided into two groups; the paracetamol group who&#xD;
      received the IV infusion of paracetamol (1.5 ml/kg); and the metoclopramide group who&#xD;
      received the IV infusion of saline (1.5 mg/kg). The presence of vomiting and the actions&#xD;
      indicative of nausea, such as repeated gagging or spitting, within 24h following general&#xD;
      anesthesia are defined as PONV. All PONV episodes and postoperative pain scores are recorded&#xD;
      during 24h postoperatively. The postoperative 0-4h and 4-24h are defined as early and late&#xD;
      postoperative period, respectively. Intravenous 4 mg ondansetron as rescue antiemetic drug is&#xD;
      administered in case of two or more vomiting episodes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 20, 2018</start_date>
  <completion_date type="Actual">August 21, 2018</completion_date>
  <primary_completion_date type="Actual">August 20, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preventing of postoperative nausea and vomiting</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Preventing of postoperative nausea and vomiting in postoperative care unit</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Perfalgan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1.5 mg/kg intravenous, intraoperative (20 min before end of the surgery)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>1.5 mg/kg intravenous, intraoperative (20 min before end of the surgery)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Perfalgan</intervention_name>
    <description>For postoperative pain</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Perfalgan</arm_group_label>
    <other_name>Paracetamol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>For postoperative nausea and vomiting</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Perfalgan</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA (the classification of the American Society of Anesthesiologists) physical status&#xD;
             I-II&#xD;
&#xD;
          -  Patients who scheduled for elective maxillofacial surgery under general anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a history of allergy to any of the study medications (opioid, general&#xD;
             anesthetic agents or paracetamol)&#xD;
&#xD;
          -  History of opioid use, hepatic or renal disease, coronary, psychotic and neurologic&#xD;
             diseases&#xD;
&#xD;
          -  Use of antiemetic, antihistaminic, analgesic or corticosteroid 24 hours (h) prior to&#xD;
             surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adnan Menderes University</last_name>
    <role>Study Director</role>
    <affiliation>Aydin Adnan Menderes University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ozlem Kocaturk</name>
      <address>
        <city>Aydin</city>
        <zip>09100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Cok OY, Eker HE, Pelit A, Canturk S, Akin S, Aribogan A, Arslan G. The effect of paracetamol on postoperative nausea and vomiting during the first 24 h after strabismus surgery: a prospective, randomised, double-blind study. Eur J Anaesthesiol. 2011 Dec;28(12):836-41. doi: 10.1097/EJA.0b013e32834c580b.</citation>
    <PMID>21986980</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2018</study_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aydin Adnan Menderes University</investigator_affiliation>
    <investigator_full_name>Ozlem Kocaturk</investigator_full_name>
    <investigator_title>Faculty of Dentisty Oral and Maxillofacial Surgery</investigator_title>
  </responsible_party>
  <keyword>PONV</keyword>
  <keyword>Paracetamol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

